Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003466664 | SCV004212173 | uncertain significance | Familial cancer of breast | 2022-11-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003500855 | SCV004320982 | uncertain significance | Ataxia-telangiectasia syndrome | 2023-09-08 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 23 of the ATM gene. It does not directly change the encoded amino acid sequence of the ATM protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ATM-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |